Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Special Protein Helps Maintain An Efficient Brain
The instruction manual for maintaining an efficient brain may soon include a section on synaptotagmin-IV (Syt-IV), a protein known to influence learning and memory, thanks to a study by University of Wisconsin-Madison researchers.
generic viagra online
New Treatments Should Be Introduced Gradually To Avoid Later Problems, Says Expert
Concerns over whether the tests a treatment undergoes before release onto the market are enough to ensure its long-term safety are raised in an editorial published by BMJ Clinical Evidence today.
News of the day
American Woman Becomes First Person With Diagnosed Multiple Sclerosis To Reach The Top Of MT Everest
American climber Lori Schneider of the US State of Wisconsin has become what is believed to be the first person with diagnosed multiple sclerosis to get to the top of Mt Everest. Lori Schneider, aged 52, reached the top of the world in the early hours of Saturday morning London time, carrying with her a banner celebrating the upcoming World MS (Multiple Sclerosis) Day on Wednesday 27 May (http://www.worldmsday.org). The banner reads: "Join the Global Movement. End MS!" (Note to picture editors: photo will be available as soon as Lori Schneider descends).
Health Insurance

Ductal Adenocarcinoma Of The Prostate: Clinical Features And Implications After Local Therapy

UroToday.com - On occasion, urologists will encounter subtypes of prostate cancer (CaP) other than adenocarcinoma. One such subtype is ductal (or endometrioid) CaP. Ductal CaP is characterized by the presence of tall, pseudostratified columnar cells with abundant cytoplasm arranged in a papillary pattern. It can be diagnosed with high Gleason score and advanced stage, but its clinical course has been relatively undefined. In the online version of Cancer, Dr. Shi-Ming Tu and colleagues report a series of 108 patients with ductal CaP. Clinical and pathological variables were retrospectively assessed in these 76 patients who had undergone radical prostatectomy (RP) or the other 32 non-surgical patients who had primarily received radiotherapy. Seventy-five surgical patients were evaluable with a median follow-up of 4.9 years. Interestingly 79% of the men who received a diagnosis of ductal CaP were found to have this subtype in the RP specimen, as opposed to detection on the initial prostate biopsy. Ten men had pure ductal subtype, 15 men had predominately ductal subtype and the other 50 patients had mixed ductal and acinar CaP. PSA, age, stage and Gleason score did not differ between the pure and mixed pathology groups. The median overall survival was 13.8 years for the pure histological group and 8.9 years for the mixed group. The median time to local progression was 2.8 years vs. 4.9 years and the median time to distant metastasis was 3.9 years vs. 2.0 years for patients who had pure ductal CaP vs. mixed ductal CaP of the prostate after RP, respectively. The majority of the non-surgical group was diagnosed by TURP and the median delivered radiotherapy dose was 70 Gy. Median overall survival for the non-surgical group was 8.2 years. The authors conclude that the increased local progression rate in the pure ductal CaP group supports a role for RP as the best option for local control. Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL Cancer. 2009 Apr 28. Epub ahead of print. doi:10.1002/cncr.24326 Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009